InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Saturday, 04/24/2021 10:57:12 AM

Saturday, April 24, 2021 10:57:12 AM

Post# of 14951
This was an interesting post by Henry M on investor village. This evening.

" (13) Catalysts the Path to SRNE Becoming a $100/stock in 2021

STI-5656 (Abivertinib) is a small molecule oral pill, should be easy to produce / scale in massive industrial quantities to meet global demand, 5656 has ENORMOUS financial potential: Covid, NSCLC, plus multiple other cancers, etc. Versus say MSC-8282 that thus far has spectacular early trial results but being a stem cell based biologic will likely be more difficult to produce and scale.

These are my SRNE price targets for the rest of the year, and if I'm half wrong I'll be a very happy investor!!

13 Catalysts:
\#1 EUA-1 Covi-Stix (May) $20 31-May
\#2 Celularity IPO - (June)
\#3 EUA-2 5656 (June) $30 30-Jun

\#4 PSS Settlement - (July)
\#5 EUA-3 MSC - (Aug)
\#6 SP-102 P3 topline read out (Aug) $60 31-Aug

\#7 EUA-4 AMG-2020 (Nov) $75
\#8 EUA-5 Covi-Trace / Tracks (Nov) $90
\#9 RTX P3 cancer / arthritis - read out (Nov)
\#10 Scilex IPO /SP-102 NDA filing (Nov) $130 30-Nov

\#11 EUA Covi-Shield (Dec)
\#12 EUA-6 Drops-2099 (Dec) $140
\#13 NDA Abiver / NSCLC (Dec) $170 31-Dec"

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News